PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Apr-2022 Wearable Medical Devices Market Analysis & Study By Product Wearable Monitoring and Diagnostic Devices, Fetal and Obstetric Devices, Continuous Glucose Monitoring Devices-2022-2031 MARKITWIRED
01-Apr-2022 Zika Virus Testing Market Research Report by Test Type: Rapid IgG/IgM Test, ELISA Test, Forecast to 2022-2031 MARKITWIRED
01-Apr-2022 Instrument Cleaners and Detergents Market: Global Industry Analysis, Growth, Share, Trends And Forecast 2022-2031 MARKITWIRED
01-Apr-2022 Automated CPR Devices Market: Worldwide Industry Analysis, Competitive Analysis, Challenges and New Market Opportunities Explored by 2022 to 2031 MARKITWIRED
01-Apr-2022 Relief Therapeutics Announces that its Subsidiary was Issued a Swiss Patent Entitled 'Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis' Relief Therapeutics Holding SA
01-Apr-2022 Stereotactic Planning Software Spending Analysis Market Current Scenario Trends, Future Insights, Comprehensive Analysis and Regional Forecast to 2022-2031 MARKITWIRED
01-Apr-2022 Spexis publishes invitation to Annual General Meeting 2022 Spexis AG
01-Apr-2022 Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19 Relief Therapeutics Holding SA
01-Apr-2022 PolyPeptide publishes invitation to the annual General Meeting 2022 PolyPeptide Group
01-Apr-2022 Straumann Group announces new Executive Management Board members to support growth strategy Straumann Holding AG
31-Mar-2022 Iktos Announces a Collaboration With Ono in Artificial Intelligence for New Drug Design Iktos
31-Mar-2022 Novartis UK response to NICE Appraisal Consultation Document (ACD) for Piqray (alpelisib) for advanced breast cancer patients Novartis
31-Mar-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Launches Capital Increase by Way of Private Placement (news with additional features) Vivoryon Therapeutics N.V.
31-Mar-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
31-Mar-2022 Avance Clinical Announces New Office Opening in Melbourne Avance Clinical
31-Mar-2022 Immutep’s efti in combination with MSD’s pembrolizumab shows encouraging antitumor activity in difficult to treat second line metastatic lung cancer patients Immutep Limited
31-Mar-2022 Fitabeo Therapeutics shortlisted for National StartUp Award Fitabeo Therapeutics
31-Mar-2022 Solvay Brussels School of Economics and Management joins forces with the Belgian life sciences ecosystem to train the next generation of Biotech and MedTech leaders Solvay Brussels School of Economics and Management
31-Mar-2022 TILT Biotherapeutics Announces Positive Update on its Phase 1 Immunotherapy Clinical Trials in Cancer TILT Biotherapeutics
31-Mar-2022 V-Bio Ventures raises EUR 110 million for its second fund and expands team V-Bio Ventures